Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2014 079 370.3 |
96 | EP file number | EAKZ | 14 74 6114.9 |
86 | WO file number | WAKZ | PCT/US2014/014490 |
97 | EP publication number | EPN | 2951205 |
87 | WO publication number | WPN | 2014121221 |
54 | Designation/title | TI | ANTI-AKTIVIN-A-VERBINDUNGEN ZUR BEHANDLUNG VOM OVARIALKREBS |
51 | IPC main class | ICM (ICMV) | A61K 47/68 (2017.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 38/17 (2006.01), C07K 16/26 (2006.01), C07K 16/00 (2006.01), A61K 31/395 (2006.01), A61K 39/00 (2006.01), A61K 31/704 (2006.01), A61K 31/7068 (2006.01), A61K 39/395 (2006.01), A61K 45/06 (2006.01), C07K 16/22 (2006.01) |
22 | DE application date | DAT | Feb 3, 2014 |
96 | EP application date | EAT | Feb 3, 2014 |
86 | WO application date | WAT | Feb 3, 2014 |
43 | Date of first publication | OT | Aug 7, 2014 |
| Date of publication of grant | PET | Aug 11, 2021 |
71/73 | Applicant/owner | INH | Amgen, Inc., Thousand Oaks, Calif., US; Atara Biotherapeutics, Inc., South San Francisco, CA, US |
72 | Inventor | IN | HAN, Huiquan, Thousand Oaks, CA 91320, US; HAQQ, Christopher, Michael, South San Francisco, CA 94080, US; CIECHANOVER, Isaac, South San Francisco, CA 94080, US; ZHOU, Xiaolan, Thousand Oaks, CA 91320, US; LU, John, Zhao-nian, Thousand Oaks, CA 91320, US |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361759961 P Feb 1, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361815220 P Apr 23, 2013
|
| Due date | FT FG | Feb 28, 2026 Annual fee for the 13th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document: EP000002951205 Searchable text:
EP000002951205 Original document:
EP000002951205B1 Searchable text:
EP000002951205B1 Original document:
WO002014121221 Searchable text:
WO002014121221 |
43 | Date of first publication | EVT | Aug 7, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Dec 10, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 29, 2025 (Show all update days)(Hide all update days)- Jan 29, 2025
- Sep 19, 2024
- Procedures: Procedure relating to PCT application, Publication of PCT application, 07.08.2014: deleted
- May 9, 2024; Apr 25, 2024; Apr 11, 2024; Jan 31, 2024; Jan 27, 2023; Aug 4, 2022; Jun 30, 2022; Jan 25, 2022; Dec 23, 2021; Nov 13, 2021; Aug 26, 2021; Jul 22, 2021; Feb 18, 2021; Jan 28, 2021; Aug 9, 2018
- Historical data not available for this/these date(s)
- Dec 10, 2015
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Nov 12, 2021 |
| Issue number | HN | 51 |
| Year | PJ | 2021 |
| Publication date | VT | Dec 23, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Amgen, Inc., Thousand Oaks, Calif., US; Atara Biotherapeutics, Inc., South San Francisco, CA, US |
71/73 | Previous applicant/owner | INHF | Amgen Inc., Thousand Oaks, Calif., US, Santa Maria Biotherapeutics, Inc., South San Francisco, CA, US |
| Date of update of the procedure | REGT | Dec 23, 2021 |